CURES

All dentists who are authorized to prescribe, order, administer, furnish or dispense controlled substances must register in the Controlled Substance Utilization Review and Evaluation System (CURES) and have updated browsers to access the system. Dispensed controlled substance prescriptions are recorded in CURES, which allows prescribers to look up a patient's controlled substance current usage and past history. To register, visit oag.ca.gov/cures.

Prescribers can check CURES for misuse of prescription pads
09/20/2019
A dentist who writes controlled substance prescriptions can now review CURES (Controlled Substance Review Utilization and Evaluation System) for patients for whom the dentist is listed as a prescriber. This ability to review the list is useful when a dentist has misplaced a prescription pad or has had a prescription pad stolen or when a dentist suspects someone is misusing their DEA number.
CURES registration requirement also applies to current electronic prescribers
02/20/2019
Dentists who prescribe controlled substances electronically or through written prescription must be registered with CURES 2.0, California’s Controlled Substance Utilization Review and Evaluation System. The registration deadline was July 1, 2016. If not in compliance with the registration requirement, prescribers should register now.
New serial number required on controlled-substances prescription forms
01/17/2019
A new state law requires that tamper-resistant prescription forms for controlled substances have unique serial numbers. These numbers will be linked to corresponding records in California’s prescription-drug monitoring program known as CURES. The requirement is part of Assembly Bill 1753 signed into law last September. New prescription forms should be ordered from a “serial # compliant printer” as indicated on the DOJ’s website.
New opioid laws will affect dentistry in 2019 and beyond
10/31/2018
Many bills were introduced over the past year to combat the opioid epidemic in California, as CDA previously reported. Here is an overview of CDA-supported legislation in the areas of e-prescribing, informed consent, interstate data sharing and prescription-pad requirements, that Gov. Jerry Brown signed into law in September and how these bills will affect the practice of dentistry.
Rules for storing and disposing of controlled substances
09/24/2018
A dentist who stores controlled substances must follow both state and federal rules for storage, inventory and disposal of those drugs. DEA registration is required for each address where a dentist stores controlled substances.
Mandatory CURES consultation in effect Oct. 2
09/19/2018
Beginning Oct. 2, all licensees authorized to prescribe, order, administer, furnish or dispense controlled substances in California must, with some exceptions, check a patient’s prescription history in CURES 2.0 before prescribing a Schedule II-IV substance, as CDA first reported in April. One notable exemption to mandatory CURES consultation that applies to dental care and that CDA helped secure is summarized here.
July 19 webinar will address the opioid crisis, prescribing trends
07/16/2018
A free lunchtime webinar on Thursday, July 19, will examine the current state of the nation’s opioid crisis, including deaths from prescription and illicit opioids, prescribing trends and some of the efforts being made to address the crisis. The one-hour webinar is hosted by the ADA and presented by Dr. Scott Winiecki, team lead for the Food and Drug Administration’s Safe Use Initiative.
CDA-supported bills modify opioid prescribing, CURES requirements
06/07/2018
At least 130 bills to combat the nation’s opioid epidemic have been introduced in U.S. Congress since January, and California is mounting its own legislative efforts to curb opioid abuse. CDA has identified 19 bills in the current session that can be classified into five main categories of opioid legislation. Among these, CDA is taking an official support position on five bills and a support if amended position on a sixth. A summary of the bills and how they may impact the way dentists practice and prescribe follows.
Mandatory checks in CURES take effect Oct. 2
04/19/2018
The Department of Justice announced that California’s Controlled Substance Utilization Review and Evaluation System, also known as CURES 2.0, is ready for statewide use and that mandatory CURES consultation becomes effective Oct. 2, 2018. Beginning on this date, prescribers must check a patient’s prescription history in CURES 2.0 before prescribing a Schedule II-IV substance, with some exceptions.
Legislation, CDA Presents lecture, address prescription opioid abuse and CURES
04/16/2018
On the legislative front, in California alone, more than two dozen bills that address opioid prescription and misuse are working their way through the Legislature, including several by Assemblymember Jim Wood, DDS. Meanwhile, CDA continues to provide education and resources on opioid prescribing to members and dentists throughout California. In May at CDA Presents The Art and Science of Dentistry in Anaheim, CDA Public Affairs will host “Clinical and Legal Considerations for Prescribing Controlled Substances.”
ADA advances national policy to reduce opioid dependency
03/28/2018
The ADA on March 26 adopted a new policy to combat the opioid epidemic, calling it the potential first of its kind by a major health professional organization to support mandates on opioid prescription limits and continuing education. “I call upon dentists everywhere to double down on their efforts to prevent opioids from harming our patients and their families,” said ADA President Joseph P. Crowley, DDS, in a press release. The Interim Board Policy on Opioid Prescribing addresses continuing education, dosage and duration, and prescription and drug monitoring.
Dentists with DEA numbers must be registered with CURES 2.0
02/21/2018
“All health care practitioners authorized to prescribe or dispense Schedule II-IV controlled substances were required to register to use CURES 2.0 no later than July 1, 2016,” the Dental Board of California reminds dentists in an email distributed late January. California’s Controlled Substance Utilization Review and Evaluation System aids prescribers and dispensers in identifying fraudulent activity and is intended to reduce prescription drug abuse and diversion.
Resources for dentists as opioid crisis declared public health emergency
11/13/2017
With the U.S. Department of Health and Human Services on Oct. 26 declaring the opioid crisis a public health emergency, CDA reminds dentists, who prescribe approximately 11 percent of prescription opioids annually, of the resources available to them. CDA’s online opioid resource guide at cda.org/opioid is regularly updated with links to resources as they are published.
CVS Health expands fight against opioid abuse
10/25/2017
CVS Health launched a new initiative in September to help fight the national opioid abuse epidemic by enhancing opioid utilization management, providing drug disposal kiosks nationwide and aiding local communities in treatment and recovery services. The president and CEO of CVS Health said in a news release that addressing the nation’s opioid crisis calls for a multipronged effort involving many health care stakeholders, including dentists.
Policy statement on opioid abuse adopted by dental board
10/10/2017
In California alone, opioid-related deaths from 2002 to 2014 were up almost 30 percent, and dentists prescribe up to 12 percent of all opioid prescriptions in the U.S. In light of these alarming statistics, the Dental Board of California in August 2017 finalized and adopted a policy statement recognizing the epidemic of opioid abuse in the U.S.
CURES 'red flags' covered in San Francisco course
07/18/2017
Dentists prescribe approximately 11 percent of prescription opioids annually in the U.S. With this in mind, CDA Public Affairs is sponsoring a course to be held at CDA Presents The Art and Science of Dentistry in San Francisco this August that will help dental professionals understand their role in drug diversion programs, including the use of California’s prescription drug monitoring program known as CURES.
CURES fee exemption available for some dentists
06/22/2017
California prescribers who are registered with the U.S. Drug Enforcement Agency to prescribe, dispense or administer controlled substances must also register to access the state’s prescription drug monitoring program, CURES. A $6 annual ($12 biennial) fee is assessed with licensure renewal in order to maintain the database.
Course helps dentists respond to opioid abuse epidemic
04/18/2017
Dentists prescribe approximately 11 percent of prescription opioids annually in the U.S. A course at CDA Presents in Anaheim will help dental professionals understand the ever-growing problem of prescription drug abuse and dentists' role in drug diversion programs, including the use of California's prescription drug monitoring program known as CURES, Controlled Substance Utilization Review and Evaluation System.
CDA updates guide to the California Dental Practice Act
03/22/2017
“Your Guide to California Dental Practice Act Compliance” was updated in January 2017 to reflect new laws concerning adverse event reporting, scope of practice, required language in the anesthesia informed consent form, online advertising through Groupon, notice of licensure, prescriber dispensing of controlled substances and several other areas of practice.
CDA offers new CURES and opioid resource guide
03/20/2017
CDA has created a new online resource guide to help dentists meet requirements and follow best practices when prescribing opioids for the treatment of patients' dental pain. This resource is CDA's latest in ongoing efforts to address and combat California's opioid epidemic and ensure members have the most up-to-date information to maintain compliance in the dental practice.
CURES 1.0 not available after March 5
02/08/2017
CURES 1.0 will be discontinued on Sunday, March 5, 2017. The departments of Consumer Affairs and Justice have announced that beginning March 6 prescribing health care practitioners will only be able to access CURES 2.0. To securely access CURES 2.0, dentists will need to update their web browsers as specified.
'Are you in compliance' with 2016 laws and regulations?
12/22/2016
From displaying California's Whistleblower Protection notice to registering with CURES 2.0, dental practices were to comply with 12 laws and regulations that took effect in 2016. Presented here are summaries of these new laws and regulations along with explanations of what dentists must do to comply with them.
Gov. Brown signs CDA-sponsored loan repayment bill
10/06/2016
In the final weeks of the state’s 2016 legislative session, Gov. Brown signed into law several bills that impact dentists, including CDA-sponsored Assembly Bill 2485 (Santiago, D-Los Angeles). Taking effect immediately as an urgency statute, AB 2485, the Dental Corps Loan Repayment Program, revises in the applicant’s favor provisions regarding program eligibility, application, selection and placement.
Prescription drug abuse lecture at CDA Presents
08/18/2016
A lecture will be held at CDA Presents The Art and Science of Dentistry in San Francisco to help dentists navigate the professional responsibilities and regulatory requirements of pain management and opioid diversion.
CURES: mandatory check proposed
07/27/2016
A check of the state’s prescription drug monitoring program may become mandatory under a proposed bill requiring prescribers, including dentists with U.S. Drug Enforcement Administration registrations, to check the Controlled Substance Utilization Review and Evaluation System when writing a prescription for Schedule II-IV medications.
CURES webinar recording now available
06/06/2016
CDA recently hosted a webinar, presented by the Department of Justice, to assist member dentists with the Controlled Substance Utilization Review and Evaluation System (CURES 2.0) registration process and any questions they may have regarding the new system.
CURES registration deadline July 1
05/27/2016
All prescribers in California with U.S. Drug Enforcement Administration registrations are required to register by July 1 to access California’s prescription drug monitoring program, known as CURES 2.0 (Controlled Substance Utilization Review and Evaluation System).
CURES webinar offers important registration tips
05/18/2016
CDA is hosting a webinar, presented by the Department of Justice, on May 25 to assist member dentists with the Controlled Substance Utilization Review and Evaluation System (CURES 2.0) registration process and any questions they may have regarding the new system.
Time to register for CURES
04/21/2016
All prescribers in California with U.S. Drug Enforcement Administration (DEA) registrations are required to register by July 1 to access California’s prescription drug monitoring program, known as CURES 2.0 (Controlled Substance Utilization Review and Evaluation System). Additionally, prescribers must have updated browsers to access the system.
You're registered with CURES - now what?
03/08/2016
All prescribers in California with U.S. Drug Enforcement Administration (DEA) registrations are required to register by July 1 to access California's prescription drug monitoring program, known as CURES 2.0 (Controlled Substance Utilization Review and Evaluation System). Here are some common questions and answers for dentists related to the use of CURES.
CURES 2.0 enrollment now open to dentists
01/13/2016
All dentists who are authorized to prescribe, order, administer, furnish or dispense controlled substances must register in the Controlled Substance Utilization Review and Evaluation System (CURES) by July 1 and have updated browsers to access the system. Dispensed controlled substance prescriptions are recorded in CURES, which allows prescribers to look up a patient's controlled substance current usage and past history.
CURES enrollment deadline moved to July 1
10/19/2015
The CURES enrollment deadline for providers has officially been pushed back from Jan. 1 to July 1 of 2016. The change comes after the governor signed AB 679 (Allen). The bill was amended late in the legislative session due to concern that the most recent Controlled Substance Utilization Review and Evaluation System (CURES) update has fallen behind schedule. The CURES 2.0 was planned to be in use by July 1 of this year, yet the system is still not fully operational. The delay will give the Department of Justice (DOJ) time to finalize CURES 2.0 and for providers to enroll.
CURES enrollment deadline expected to be pushed back
09/22/2015
The CURES enrollment deadline for providers will be pushed back from Jan. 1 to July 1 of 2016, if the governor signs a bill. The CURES 2.0 was planned to be in use by July 1 of this year, yet the system is still not fully operational. The delay will give the Department of Justice (DOJ) time to finalize CURES 2.0 and providers to enroll.
What dentists need to know about new CURES system
08/25/2015
All dentists who are authorized to prescribe, order, administer, furnish or dispense controlled substances must register for the Controlled Substance Utilization Review and Evaluation System (CURES) by Jan. 1, 2016. CDA Update staff asked the Department of Justice about the new CURES 2.0 system and what dentists should do to register and ensure their systems are compatible.
Prescription drug database changes looming
07/28/2015
All dentists who are authorized to prescribe, order, administer, furnish or dispense controlled substances must register for the Controlled Substance Utilization Review and Evaluation System (CURES) by Jan. 1, 2016. In addition, the Department of Justice and the Department of Consumer Affairs recently announced that a new CURES 2.0 went live on July 1. This upgraded prescription drug monitoring program features a variety of performance improvements and added functionality.
Topics
Search
Enter Keywords
Filter by Date
From :  
To      :